7Baggers

Endava plc
(NYSE:DAVA) 

DAVA stock logo

Endava plc provides technology services for clients in the consumer products, healthcare, logistics, and retail verticals in Europe, Latin America, and North America. It offers technology and digital advisory services for financial services, healthcare, manufacturing, retail and consumer, business a...

Founded: 2000
Full Time Employees: 7,199
Sector: Technology
Industry: Software-Infrastructure

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-10-11 2018-09-30 2018-06-30 
                                   
      revenue
    178,187 186,776 194,838 195,589 195,052 194,418 174,365 371,973 188,421 189,791 203,532 205,241 196,169 180,404 169,220 157,668 147,465 133,622 112,311 200,365 95,125 90,463 92,235 85,900 82,352 76,618 73,064 71,834  66,414  
      yoy
    -8.65% -3.93% 11.74% -47.42% 3.52% 2.44% -14.33% 81.24% -3.95% 5.20% 20.28% 30.17% 33.03% 35.01% 50.67% -21.31% 55.02% 47.71% 21.77% 133.25% 15.51% 18.07% 26.24% 19.58%  15.36%      
      qoq
    -4.60% -4.14% -0.38% 0.28% 0.33% 11.50% -53.12% 97.42% -0.72% -6.75% -0.83% 4.62% 8.74% 6.61% 7.33% 6.92% 10.36% 18.97% -43.95% 110.63% 5.15% -1.92% 7.37% 4.31% 7.48% 4.86% 1.71%     
      cost of sales
                                   
      direct cost of sales
    -134,039 -133,577 -134,251 -143,546 -139,520 -142,996 -130,452 -259,412 -127,319 -123,968 -132,458 -126,282 -122,971 -117,027 -108,092 -99,806 -89,486 -82,052 -69,176 -120,479 -57,476 -58,871 -51,889 -73,828 -48,764 -46,796 -44,330 -42,668  -40,358  
      allocated cost of sales
    -6,484 -6,763 -6,998 -7,025 -6,873 -8,250 -6,720 -13,218 -6,632 -6,301 -6,433 -6,460 -5,783 -5,618 -5,707 -5,800 -5,290 -6,225 -4,621 -9,912 -4,732 -4,545 -4,591 -4,391 -3,921 -3,901 -3,745 -3,737  -3,569  
      total cost of sales
    -140,523 -140,340 -141,249 -150,571 -146,393 -151,246 -137,172 -272,630 -133,951 -130,269 -138,891 -132,742 -128,754 -122,645 -113,799 -105,606 -94,776 -88,277 -73,797 -130,391 -62,208 -63,416 -56,480 -78,219 -52,685 -50,697 -48,075 -46,405  -43,927  
      gross profit
    37,664 46,436 53,589 45,018 48,659 43,172 37,193 99,343 54,470 59,522 64,641 72,499 67,415 57,759 55,421 52,062 52,689 45,345 38,514 69,974 32,917 27,047 35,755 7,681 29,667 25,921 24,989 25,429  22,487  
      yoy
    -22.60% 7.56% 44.08% -54.68% -10.67% -27.47% -42.46% 37.03% -19.20% 3.05% 16.64% 39.26% 27.95% 27.38% 43.90% -25.60% 60.07% 67.65% 7.72% 811.00% 10.95% 4.34% 43.08% -69.79%  15.27%      
      qoq
    -18.89% -13.35% 19.04% -7.48% 12.71% 16.08% -62.56% 82.38% -8.49% -7.92% -10.84% 7.54% 16.72% 4.22% 6.45% -1.19% 16.20% 17.74% -44.96% 112.58% 21.70% -24.35% 365.50% -74.11% 14.45% 3.73% -1.73%     
      gross margin %
    21.14% 24.86% 27.50% 23.02% 24.95% 22.21% 21.33% 26.71% 28.91% 31.36% 31.76% 35.32% 34.37% 32.02% 32.75% 33.02% 35.73% 33.94% 34.29% 34.92% 34.60% 29.90% 38.77% 8.94% 36.02% 33.83% 34.20% 35.40% NaN% 33.86%  
      selling, general and administrative expenses
    -40,575 -37,746 -37,135 -43,345 -43,969 -41,925 -39,025 -78,618 -38,363 -36,142 -37,916 -37,364 -38,878 -32,195 -29,989 -31,981 -27,643 -25,553 -20,476 -44,261 -21,267 -20,185 -21,614 -19,139 -17,340 -17,248 -17,601 -16,345  -14,662  
      operating profit
    -2,911 8,690 16,454 1,673 4,690 1,247 -1,832 20,725 16,107 22,713 30,104 32,795 27,233 26,651 25,418 19,430 23,885 19,788 18,038 25,713 11,650 6,862 14,141 -11,458 12,327 8,673 7,388 9,084  7,825  
      yoy
    -162.07% 596.87% -998.14% -91.93% -70.88% -94.51% -106.09% -36.80% -40.85% -14.78% 18.44% 68.79% 14.02% 34.68% 40.91% -24.44% 105.02% 188.37% 27.56% -324.41% -5.49% -20.88% 91.40% -226.13%  10.84%      
      qoq
    -133.50% -47.19% 883.50% -64.33% 276.10% -168.07% -108.84% 28.67% -29.08% -24.55% -8.21% 20.42% 2.18% 4.85% 30.82% -18.65% 20.70% 9.70% -29.85% 120.71% 69.78% -51.47% -223.42% -192.95% 42.13% 17.39% -18.67%     
      operating margin %
    -1.63% 4.65% 8.44% 0.86% 2.40% 0.64% -1.05% 5.57% 8.55% 11.97% 14.79% 15.98% 13.88% 14.77% 15.02% 12.32% 16.20% 14.81% 16.06% 12.83% 12.25% 7.59% 15.33% -13.34% 14.97% 11.32% 10.11% 12.65% NaN% 11.78%  
      net finance expense
    -5,561                   -6,380          -5,191  
      profit for the period before tax
    -8,472                               
      tax on profit on ordinary activities
    315 -2,631 -2,651 4,347 -1,966 -1,445 -1,208 -7,205 -4,947 -1,878 -6,030 -5,252 -6,840 -5,452 -5,787 -3,670 -4,377 -2,577 -3,511 -4,826 -2,017 -640 -3,689 3,441 -2,958 -2,219 -1,290 -1,998  -586  
      profit for the period
    -8,157 5,011 10,946 6,851 2,247 4,744 -1,737  12,366 17,776.25 24,358 15,019 31,728 14,013.5 20,103 15,406 20,545 6,873.25 12,986 14,507 6,708 3,825.25 14,605 -13,816        
      other comprehensive income
                                   
      items that may be reclassified subsequently to profit or loss:
                                   
      exchange differences on translating foreign operations and net investment hedge impact
    6,593 -18,822 -7,741 9,527 -23,340                           
      total comprehensive expense for the year attributable to the equity holders of the company
    -1,564                               
      earnings per share:
                                   
      weighted-average number of shares outstanding - basic
    53,037,125 58,461,621 59,164,297 59,488,389 59,051,116 58,318,968 58,439,085 58,101,072 57,901,454 57,314,839 57,603,730 57,219,704 56,705,849 56,272,036 56,585,768 56,173,171 55,649,000 55,220,298 55,581,888 54,831,134 54,494,227 53,423,575 53,815,137 53,140,682 52,556,332 50,116,979 49,500,875 49,454,195    
      weighted-average number of shares outstanding - diluted
    53,193,752 58,875,460 59,434,080 59,628,436 59,430,225 58,749,497 58,799,599 58,367,296 58,438,198 58,082,388 58,210,601 57,959,580 58,128,971 58,018,200 57,999,337 58,019,316 57,792,616 57,050,613 57,203,008 56,850,290 56,639,638 56,065,080 56,345,433 55,957,472 55,422,182 55,026,223 54,912,822 54,892,513  53,842,639  
      basic
    -0.15                               
      diluted
    -0.15                               
      net finance income
     -4,891 -2,857 831 -477 -1,656 1,303 7,193 1,206 2,223 284 -12,524 11,335 5,840 472 -354 1,037 -1,263 -1,541  -2,925 -113 4,153 -5,799 2,928 -1,161 216 331    
      profit before tax
     3,799 13,597 2,504 4,213 -409 -529 27,918 17,313 24,936 30,388 20,271 38,568 32,491 25,890 19,076 24,922 18,525 16,497 19,333 8,725 6,749 18,294 -17,257 17,470 10,447 7,604 9,415  2,634  
      total comprehensive income for the period attributable to owners of the company
     -377.5 3,205 16,378 -21,093                           
      earnings per share
                                   
      weighted-average number of shares outstanding - diluted
    53,193,752 58,875,460 59,434,080 59,628,436 59,430,225 58,749,497 58,799,599 58,367,296 58,438,198 58,082,388 58,210,601 57,959,580 58,128,971 58,018,200 57,999,337 58,019,316 57,792,616 57,050,613 57,203,008 56,850,290 56,639,638 56,065,080 56,345,433 55,957,472 55,422,182 55,026,223 54,912,822 54,892,513  53,842,639  
      basic eps
     0.085 0.19 0.12 0.04 0.083 -0.03 0.36 0.21 0.31 0.42 0.26 0.56 0.25 0.36 0.27 0.37 0.125 0.23 0.26 0.12 0.073 0.27 -0.26 0.28 0.08 0.13 0.15  0.04  
      diluted eps
     0.085 0.18 0.11 0.04 0.08 -0.03 0.35 0.21 0.305 0.42 0.26 0.55 0.243 0.35 0.27 0.36 0.12 0.23 0.26 0.12 0.068 0.26 -0.25 0.26 0.073 0.11 0.14  0.04  
      £’000
                                   
      exchange differences on translating foreign operations
         -265.25 -2,930 1,869 4,742 -6,998 -3,824 -7,157 7,980 5,393 2,715 -3,577 2,049 -270 -6,021 -3,491 -847 1,358 787 -2,460 -1,925 -3,622 -3,027 930    
      total comprehensive income for the period attributable to owners of the parent
         4,478.75 -4,667  17,108 17,026 20,534 7,862 39,708 14,310.25 22,818 11,829 22,594 4,495.25 6,965 11,016 5,861 2,925.75 15,392 -16,276 12,587 3,353.5 3,287 8,347    
      note
                                   
      profit for the year and profit attributable to the equity holders of the company
           20,713                        
      total comprehensive income for the year attributable to the equity holders of the company
           22,582                        
      net impairment gains on financial assets
             -66.25 3,379  -1,304                   
      net impairment losses on financial assets
               -2,340  1,087 -14 -651 -1,161               
      gain on sale of subsidiary
                            2,215       
      profit for the period and profit attributable to owners of the parent
                            14,512 3,944.75 6,314 7,417  2,048  
      weighted-average number of shares outstanding
                                 48,258,033  
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2024-06-30 2024-03-31 
        
        assets - non-current
        
        goodwill
      515,724 264,289 
        intangible assets
      127,797 57,179 
        property, plant and equipment
      20,638 22,204 
        lease right-of-use assets
      53,294 52,645 
        deferred tax assets
      18,323 19,924 
        financial assets and other receivables
      10,499 7,380 
        total
      746,275 423,621 
        assets - current
        
        trade and other receivables
      193,673 175,671 
        corporation tax receivable
      11,402 2,960 
        financial assets
      183 185 
        cash and cash equivalents
      62,358 190,021 
        total assets
      1,013,891 792,458 
        liabilities - current
        
        lease liabilities
      14,450 14,300 
        trade and other payables
      116,569 82,262 
        corporation tax payable
      8,556 3,062 
        contingent consideration
      8,444 4,619 
        deferred consideration
      5,840 3,205 
        liabilities - non-current
        
        borrowings
      144,754  
        deferred tax liabilities
      30,814 13,297 
        other liabilities
      509 548 
        equity
        
        share capital
      1,180 1,169 
        share premium
      21,280 21,208 
        merger relief reserve
      63,440 49,643 
        retained earnings
      573,640 570,878 
        other reserves
      -20,059 -18,079 
        investment in own shares
      -26 -26 
        total liabilities and equity
      1,013,891 792,458 
        share capital £’000
        
        balance at 30 june 2021
      247  
        equity-settled share-based payment transactions - net of tax
        
        issuance of shares related to acquisitions
        
        exercise of options
      8,905  
        hyperinflation adjustment
        
        transaction with owners
      8,905  
        profit for the year
        
        other comprehensive income
        
        total comprehensive income for the year
        
        balance at 30 june 2022
      9,152  
        other comprehensive expense
        
        balance at 30 june 2023
      14,625  
        balance at 30 june 2024
      21,280  
        liabilities - non current
        
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-03-31 2023-12-31 2023-09-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-03-31 2019-12-31 2019-09-30 2019-03-31 2018-12-31 2018-09-30 
                                
          operating activities
                                
          profit for the period
        -8,157 21,212 20,044 9,098 2,247 18,976  12,366 71,105 46,747 31,728 56,054 35,951 20,545 43,441 27,493 7,799 6,708 15,301 696 14,512 15,779 9,465 2,048 
          income tax charge
        -315 2,901 270 -2,381 1,966 8,413 2,258 4,947 18,122 12,092 6,840 13,834 8,047 4,377 10,914 8,337 2,809 2,017 3,206  2,958 3,874 2,584 586 
          non-cash adjustments
        19,992 81,609 64,720 46,207 23,593 43,760 16,033 15,800 40,216 24,974 6,099 46,228 32,970 14,742 55,547 39,088 15,069 12,417 20,062 15,886 1,956 18,270 13,305  
          tax received
        5,681             -2,233           
          research & development credit received
        97                        
          net changes in working capital
        -5,046 -40,186 -23,010 -12,716 -22,112 -8,811 10,864 -14,178 -22,063 -7,635 -17,821 -33,322 -16,396 -17,522 -21,360 -23,626 -5,775 176 4,223 13,936 -3,185 -11,271 -10,778 -7,588 
          net cash from operating activities
        12,252 52,773 55,081 36,422 4,374 54,631 35,036 16,587 91,191 66,131 25,236 73,607 54,871 19,909 88,352 53,434 20,413 21,470 38,346 26,500 15,409 24,289 11,665 2,051 
          capital expenditures
          free cash flows
        12,252 52,773 55,081 36,422 4,374 54,631 35,036 16,587 91,191 66,131 25,236 73,607 54,871 19,909 88,352 53,434 20,413 21,470 38,346 26,500 15,409 24,289 11,665 2,051 
          investing activities
                                
          purchase of non-current assets
        -3,090 -4,703 -2,932 -1,571 -1,135 -3,696 -1,393 -807 -11,804 -7,591 -3,443 -10,195 -7,398 -3,562 -6,113 -3,752 -1,703 -641 -8,075 -5,830 -2,506 -5,153 -3,964 -1,894 
          proceeds from disposal of non-current assets
        47 339 255  36 36  148 16 19 241 171 112 193 150 43 65 150 120 13 33   
          payment for acquisition of subsidiary, net of cash acquired
        -3,487 -6,831 -6,676 -5,900 -68 -19,223 -2,528 -4,182 -35,773 -32,397               
          interest received
        694 1,256 978 720 367 5,599 1,957 1,565 1,851 797 365 65 20 84 76 26 27 477 353 199 286 126 74 
          net cash from investing activities
        -5,836 -9,939 -8,375 -6,715 -800 -23,964 -1,994 -10,101 -45,578 -39,175 -3,059 -20,024 -7,818 -4,052 -107,094 -66,746 -2,976 -49,736 -28,010 -26,385 -1,239 -7,976 -3,813 -1,820 
          financing activities
                                
          proceeds from borrowings
        10,000 85,562                    3,500 3,500  
          repayment of borrowings
         -43,404 -40,842 -30,842 -7,000              -955 -9 -9 -23,538 -23,526 -20,015 
          proceeds from sublease
        23 127 92 64 30 129 31 56 325 237 145 418 277 135 565 424 132 157 406 302 154    
          repayment of lease liabilities
        -2,898 -12,425 -9,357 -6,159 -3,093 -10,793 -3,500 -3,920 -9,960 -6,491 -3,099 -10,468 -7,123 -3,801 -11,828 -8,442 -2,792 -2,954 -7,157 -4,569 -2,156    
          repayment of lease interest
        -417 -1,864 -1,447 -989 -507                    
          grant received
         274 274 274 274 822 23 207 472 220  90 43 228 267 -89 309 661 661 564 1,784 1,784 105 
          interest and debt financing costs paid
        -2,468 -8,635 -6,510 -4,282 -2,252 -1,611 -296 -287 -3,532                
          payment for repurchase of own shares
        -22,917 -64,765 -17,808                      
          net cash from financing activities
        -18,677  -40,598 -31,934 -12,548 -4,867 -624 -3,933 -8,297   -3,289 -2,979 -3,914 -11,920 -8,416 -2,981 -2,691 7,210 10,816 -1,604 26,379 26,364  
          net change in cash and cash equivalents
        -12,261 -2,296 6,108 -2,227 -8,974 25,800 32,418 2,553 37,316 22,765 19,027 50,294 44,074 11,943 -30,662 -21,728 14,456 -30,957 17,546 10,931 12,566 42,692 34,216 25,001 
          cash and cash equivalents at the beginning of the period
        59,345 62,358 62,358 62,358 62,358 164,703  164,703 162,806 162,806 162,806 69,884 69,884 69,884 101,327 101,327 101,327 70,172 70,172 70,172 15,048 15,048 15,048 
          effects of exchange rate changes on cash and cash equivalents
        141 -717                       
          cash and cash equivalents at the end of the period
        47,225 59,345 68,277 60,065 52,811 190,021  168,191 199,200 185,323 182,395 120,407 114,176 82,034 69,884 78,836 14,182 70,039 87,159 78,975 83,628 59,339 51,044 41,765 
          tax paid
         -12,763 -6,943 -3,786 -1,320 -7,707 -2,466 -2,348 -16,189 -10,047 -1,610 -9,187 -5,701  -3,120 -788 -800 152 -4,446 -3,535 -832 -3,641 -2,911 -1,492 
          other acquisition related settlements
              -6,680                 
          proceeds from exercise of options
             6,586 3,118 11                 
          net cash (used in)/ generated from financing activities
         -45,130                       
          other acquisition-related settlements
             -6,680                   
          proceeds from bank loans
          35,000 10,000                     
          exchange differences on cash and cash equivalents
          -189 -66 -573 -482  935 -922 -248 562 229 218 207 -781 -763 -274 -331 -559 -2,128 890 1,599 1,780 1,716 
          proceeds/(loss) from disposal of non-current assets
           36                   25  
          profit for the year
                                
          research and development credit received
                                
          net cash generated from financing activities
                                
          cash and cash equivalents at the beginning of the year
                                
          net foreign exchange differences
                                
          cash and cash equivalents at the end of the year
                                
          note
                                
          (loss) / proceeds from disposal of non-current assets
                                
          uk research and development credit received
                      2,930 2,930      1,278   
          issue of shares
                4,398 2,266 21 7,366 4,299  26 61 85   
          interest paid
                 -423 -217 -695 -475 -249 -911 -674 -233 -211 -603 -375 -166 -280 -222 -148 
          net cash (used in)/from financing activities
                 -4,191 -3,150              
          proceeds from sale of subsidiary, net of cash disposed of
                                
          proceeds from sale of shares
                                
          acquisition of subsidiaries, consideration in cash
                   -10,711 -611 -611           
          cash and cash equivalents acquired with subsidiaries
                   576   8,733 2,722 1,603 3,289 3,289     
          acquisition of business / subsidiaries, consideration in cash
                      -109,991 -65,942         
          proceeds from sale of subsidiary net of cash disposed of
                          2,744 2,744     
          proceeds from sale of ebt shares
                          14,797 14,797     
          acquisition of business / subsidiaries
                        -1,342 -50,790 -26,595 -27,061  -3,142   
          net proceeds from initial public offering
                             44,828 44,828 44,828 
          income tax charge/
                           -483     
          acquisition of business / subsidiaries - settlement of deferred consideration
                            -1,523    
          proceeds from sale of subsidiary net of cash disposed
                            2,578    
          adjustments
                               8,497 
          proceeds / (loss) from disposal of non-current assets
                                
          purchase of own shares
                                
          net cash from / (used) in financing activities
                               24,770 
          dividends paid